Education
About Us
Working with TipRanks
Follow Us
RepliCel Life Sciences Inc (TSE:RP)
:RP
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 353.74K | C$ 353.74K | C$ 353.74K | C$ 353.74K | C$ 353.74K |
| Gross Profit | C$ 353.74K | C$ 353.74K | C$ 353.74K | C$ 353.74K | C$ 353.74K |
| Operating Income | C$ -1.39M | C$ -191.44K | C$ -3.17M | C$ -1.14M | C$ -2.88M |
| EBITDA | C$ -1.38M | C$ -664.49K | C$ -3.93M | C$ -1.51M | C$ -2.97M |
| Net Income | C$ -311.73K | C$ -743.23K | C$ -4.07M | C$ -1.58M | C$ -3.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 76.41K | C$ 430.27K | C$ 238.44K | C$ 51.61K | C$ 52.68K |
| Total Assets | C$ 287.79K | C$ 798.22K | C$ 591.79K | C$ 420.96K | C$ 505.47K |
| Total Debt | C$ 873.19K | C$ 40.96K | C$ 34.26K | C$ 76.03K | C$ 449.29K |
| Net Debt | C$ 814.03K | C$ -372.07K | C$ -186.93K | C$ 41.66K | C$ 425.36K |
| Total Liabilities | C$ 4.82M | C$ 6.71M | C$ 7.43M | C$ 5.48M | C$ 4.93M |
| Stockholders' Equity | C$ -4.53M | C$ -5.92M | C$ -6.84M | C$ -5.06M | C$ -4.43M |
| Cash Flow | |||||
| Free Cash Flow | C$ -1.41M | C$ -1.41M | C$ -2.51M | C$ -765.21K | C$ -2.78M |
| Operating Cash Flow | C$ -1.41M | C$ -1.41M | C$ -2.51M | C$ -765.21K | C$ -2.78M |
| Investing Cash Flow | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 11.50K | C$ -28.75K |
| Financing Cash Flow | C$ 1.06M | C$ 1.60M | C$ 2.70M | C$ 764.14K | C$ 416.00K |
RepliCel Life Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.